Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
65.25
-1.99 (-2.96%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 16.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
85.74
82.56
79.49
63.20
91.08
77.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
85.74
82.56
79.49
63.20
91.08
77.25
Raw Material Cost
49.61
52.24
44.72
41.55
62.93
46.67
Purchase of Finished goods
2.25
1.98
10.50
4.87
1.96
4.24
(Increase) / Decrease In Stocks
-0.84
-0.15
1.40
4.18
-2.10
-3.34
Employee Cost
15.16
12.96
10.54
17.34
19.15
14.37
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
12.50
10.59
9.07
21.68
23.50
14.79
Total Expenditure (Excl Depreciation)
78.68
77.62
76.23
89.62
105.44
76.73
Operating Profit (PBDIT) excl Other Income
7.06
4.94
3.26
-26.42
-14.36
0.52
Other Income
1.17
0.88
0.92
0.20
0.91
0.74
Operating Profit (PBDIT)
8.23
5.82
4.18
-26.22
-13.45
1.26
Interest
0.84
1.03
0.84
2.18
3.10
3.10
Exceptional Items
0.00
0.00
0.00
0.36
0.00
0.00
Gross Profit (PBDT)
7.39
4.79
3.34
-28.04
-16.55
-1.84
Depreciation
1.59
1.60
1.77
7.03
7.35
7.14
Profit Before Tax
5.80
3.19
1.55
-35.07
-23.90
-8.98
Tax
0.00
0.18
0.03
-7.32
-4.59
10.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5.80
3.01
1.53
-27.74
-19.31
-19.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5.80
3.01
1.53
-27.74
-19.31
-19.37
Share in Profit of Associates
18.78
-12.98
-21.12
-3.31
0.00
-0.01
Minority Interest
0.00
0.00
0.00
10.15
3.13
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
24.58
-9.97
-19.59
-20.90
-16.19
-19.38
Equity Capital
29.46
29.46
26.25
24.70
24.70
24.70
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
93.20
68.65
39.34
62.79
0.00
54.45
Earnings per share (EPS)
8.34
-3.38
-7.46
-8.46
-6.55
-7.85
Diluted Earnings per share
8.35
-3.72
-7.67
-12.57
-7.82
-6.31
Operating Profit Margin (Excl OI)
8.23%
5.98%
4.1%
-41.8%
-15.77%
0.67%
Gross Profit Margin
8.62%
5.8%
4.2%
-44.37%
-18.17%
-2.38%
PAT Margin
28.67%
-12.08%
-24.64%
-49.13%
-21.2%
-25.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 3.85% vs 3.86% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 346.54% vs 49.11% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 42.91% vs 51.53% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -18.45% vs 22.62% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Brooks Lab. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
85.74
0
85.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
85.74
0
85.74
Raw Material Cost
49.61
0
49.61
Purchase of Finished goods
2.25
0
2.25
(Increase) / Decrease In Stocks
-0.84
0
-0.84
Employee Cost
15.16
0
15.16
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
12.50
0.00
12.50
Total Expenditure (Excl Depreciation)
78.68
0
78.68
Operating Profit (PBDIT) excl Other Income
7.06
0.00
7.06
Other Income
1.17
0
1.17
Operating Profit (PBDIT)
8.23
0
8.23
Interest
0.84
0
0.84
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
7.39
0
7.39
Depreciation
1.59
0
1.59
Profit Before Tax
5.80
0
5.80
Tax
0.00
0
0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
5.80
0
5.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
5.80
0
5.80
Share in Profit of Associates
18.78
0
18.78
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
24.58
0
24.58
Equity Capital
29.46
0
29.46
Face Value
10.00
0
0.00
Reserves
93.20
0
93.20
Earnings per share (EPS)
8.34
0
8.34
Diluted Earnings per share
8.35
0
8.35
Operating Profit Margin (Excl OI)
8.23%
0%
0.00
8.23%
Gross Profit Margin
8.62%
0%
0.00
8.62%
PAT Margin
28.67%
0%
0.00
28.67%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 85.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 3.85% vs 3.86% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 24.58 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 346.54% vs 49.11% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.06 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 42.91% vs 51.53% in Mar 2025

Annual - Interest
Interest 0.84 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -18.45% vs 22.62% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.23%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025